Shree Pushkar Chemicals & Fertilisers Fund Raise of ₹45 Cr

Shree Pushkar Chemicals & Fertilisers Other Announcement

Shree Pushkar Chemicals reported no deviation in using preferential warrant funds for the quarter ended 30 September 2026. Rs.7.50 crore subscription money has been received so far.

Shree Pushkar Chemicals & Fertilisers Capital Structure Change

Shree Pushkar Chemicals' board approved reissue of forfeited shares and fund raising. Authorised capital rises to 34 million shares, subject to a 2 December 2026 vote.

Shree Pushkar Chemicals & Fertilisers Investor Presentation: Key Takeaways

Q2 FY27 revenue Rs 403.5 Cr (+58.2% YoY), EBITDA Rs 49.2 Cr (12.2% margin), PAT Rs 35.7 Cr (+96.1%). H1 revenue Rs 683.6 Cr (+34.1%). Growth driven by capacity additions.

Shree Pushkar Chemicals & Fertilisers Results Update

Shree Pushkar reported Q2 FY27 revenue of Rs 403.5 Crore, up 58.2% YoY. Profit after tax rose 96.1% to Rs 35.7 Crore in the quarter.

Shree Pushkar Chemicals & Fertilisers Q2 FY27 Results: Net Profit ₹35.7 Cr, Up 96.2% YoY

Shree Pushkar Chemicals & Fertilisers Ltd reported revenue from operations of ₹403.5 Cr (+58.2% YoY) and net profit of ₹35.7 Cr (+96.2% YoY) for Q2 FY27.

Key figure

Net profit ₹35.7 Cr · +96.2% YoY

Shree Pushkar Chemicals & Fertilisers Board Meeting Date

Shree Pushkar Chemicals schedules a 2 November 2026 board meeting for September quarter results. Agenda also includes fund raising via preferential issue and authorised capital increase.

Amba Auto Sales and Services Fund Raise of ₹161.6 Cr

Amba Auto board approved a preferential issue of up to 1.60 crore warrants at Rs 101 each. The issue aggregates Rs 161.60 Crore, subject to shareholder approval.

Value

₹161.6 Cr

Jindal Capital Fund Raise of ₹16.22 Cr

Jindal Capital's board approved a rights issue of 1,08,12,149 shares at Rs.15 each, raising Rs.16.22 Crore. The issue ratio is 3:2, with record date 06 November 2026.

Value

₹16.22 Cr

Rajkot Investment Trust Fund Raise of ₹48 Cr

Rajkot Investment Trust's board approved a Rs 48 Crore rights issue of equity shares. Pricing and record date will be set later by a committee.

Value

₹48.00 Cr

U Y Fincorp Fund Raise of ₹187.2 Cr

U.Y. Fincorp's board approved preferential issues of warrants and equity shares aggregating Rs 187.17 Crore. The issue is subject to shareholder and regulatory approvals.

Value

₹187.2 Cr

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr